Cutaneous leucocytoclastic vasculitis secondary to cabozantinib therapy for renal cell carcinoma-Reference-Cited by-同舟云学术

Cutaneous leucocytoclastic vasculitis secondary to cabozantinib therapy for renal cell carcinoma

Author:

Coltart G. S.¹²^ORCID,Sutton J. E.¹,Roche H. J.³,Sommerlad M. P.³,Crabb S. J.⁴⁵,Healy E.¹²^ORCID

Affiliation:

1. Departments ofDepartment of DermatologyUniversity Hospital Southampton NHS Foundation Trust SouthamptonHampshireUK

2. Dermatopharmacology, Clinical and Experimental Sciences Faculty of MedicineUniversity of Southampton HampshireUK

3. Department of HistopathologyUniversity Hospital Southampton NHS Foundation Trust SouthamptonHampshireUK

4. Department of Oncology University Hospital Southampton NHS Foundation Trust SouthamptonHampshireUK

5. Cancer Sciences Unit Faculty of Medicine University of Southampton Hampshire UK

Publisher

Wiley

Subject

Dermatology

Link

Reference5 articles.

3. Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: a case report and review of the literature;Fekete GL;Exp Ther Med,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Cabozantinib;Reactions Weekly;2021-06